ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Recursos principais

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
AI Entrar Premium IconPremium Help Menu
Índice Bovespa
125.235,54
-0,34%
S&P 500
6.047,15
0,81%
US Dollar vs BRL
6,0584
0,00%
Bitcoin
96.056,04
0,20%
Brent Oil
71,885
-0,01%
Registration Strip Icon for tools Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Onconova Therapeutics Inc (ONTX)

  7. Onconova Therapeutics Inc (ONTX) Notícias

ONTX

Onconova Therapeutics (ONTX)

Onconova Therapeutics Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:ONTX
DataHoraFonteTítuloCódigoCompanhia
09/02/202419:38Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ONTXOnconova Therapeutics Inc
08/02/202418:09Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ONTXOnconova Therapeutics Inc
27/10/202317:35Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:ONTXOnconova Therapeutics Inc
29/09/202318:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ONTXOnconova Therapeutics Inc
14/08/202318:28Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ONTXOnconova Therapeutics Inc
21/07/202317:50Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:ONTXOnconova Therapeutics Inc
12/07/202301:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:ONTXOnconova Therapeutics Inc
30/06/202317:46Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:ONTXOnconova Therapeutics Inc
13/06/202317:55Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ONTXOnconova Therapeutics Inc
07/06/202317:31Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:ONTXOnconova Therapeutics Inc
15/05/202318:29Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ONTXOnconova Therapeutics Inc
30/03/202317:47Edgar (US Regulatory)Annual Report (10-k)NASDAQ:ONTXOnconova Therapeutics Inc
19/12/202220:53Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:ONTXOnconova Therapeutics Inc
15/11/202218:32Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:ONTXOnconova Therapeutics Inc
15/11/202210:25TipRanksNoble Financial Keeps Their Buy Rating on Onconova Therapeutics (ONTX)NASDAQ:ONTXOnconova Therapeutics Inc
15/11/202208:16TipRanksH.C. Wainwright Keeps Their Hold Rating on Onconova Therapeutics (ONTX)NASDAQ:ONTXOnconova Therapeutics Inc
13/09/202209:05TipRanksNoble Financial Sticks to Their Buy Rating for Onconova Therapeutics (ONTX)NASDAQ:ONTXOnconova Therapeutics Inc
12/08/202207:26TipRanksH.C. Wainwright Sticks to Their Hold Rating for Onconova Therapeutics (ONTX)NASDAQ:ONTXOnconova Therapeutics Inc
13/05/202217:22Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ONTXOnconova Therapeutics Inc
12/05/202209:05TipRanksNoble Financial Remains a Buy on Onconova Therapeutics (ONTX)NASDAQ:ONTXOnconova Therapeutics Inc
12/05/202207:15TipRanksOnconova Therapeutics (ONTX) Gets a Hold Rating from H.C. WainwrightNASDAQ:ONTXOnconova Therapeutics Inc
29/04/202218:04Edgar (US Regulatory)Amended Annual Report (10-k/a)NASDAQ:ONTXOnconova Therapeutics Inc
04/04/202209:25TipRanksAnalysts Offer Insights on Healthcare Companies: Onconova Therapeutics (ONTX), Baudax Bio (BXRX) and 4d Pharma (LBPS)NASDAQ:ONTXOnconova Therapeutics Inc
21/03/202209:25TipRanksNoble Financial Thinks Onconova Therapeutics’ Stock is Going to RecoverNASDAQ:ONTXOnconova Therapeutics Inc
18/03/202207:17TipRanksH.C. Wainwright Sticks to Its Hold Rating for Onconova Therapeutics (ONTX)NASDAQ:ONTXOnconova Therapeutics Inc
14/02/202217:21Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ONTXOnconova Therapeutics Inc
02/12/202113:35TipRanksOnconova Therapeutics (ONTX) Receives a Hold from H.C. WainwrightNASDAQ:ONTXOnconova Therapeutics Inc
01/10/202112:02Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:ONTXOnconova Therapeutics Inc
28/09/202117:05GlobeNewswire Inc.Onconova Therapeutics, Inc. Announces Closing of $21 Million Public Offering of Common StockNASDAQ:ONTXOnconova Therapeutics Inc
24/09/202109:00GlobeNewswire Inc.Onconova Therapeutics, Inc. Announces Pricing of $21 Million Public Offering of Common StockNASDAQ:ONTXOnconova Therapeutics Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:ONTX

Seu Histórico Recente

USOTC
RKUNF
Rakuten (PK)
AQSE
HMEF.GB
HSBC Securities Services...
BIT
UC5R45
Unicredit Bank
BIT
UB51MK
Unicredit Bank
BIT
F30714
Vontobel Financial Produ...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados

BLACK FRIDAY

ADVFN

Celebrating 25 years Est 1999-2024

Economize até 50%* para TRADER BRASIL

1 ano 30%, 2 anos 40% e *3 anos 50%

*Ao longo de 3 anos $ 881.64 apenas $ 440.82